All In Biotech

Free tool

FAERS Monitor: Cardizem Cd

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020062 or its brand name (Cardizem Cd, Diltiazem Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

14,723

Serious

12,051

82% of reports

Hospitalization

6,837

Death reported

3,123

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,626
  • pain1,418
  • fatigue1,372
  • fall1,184
  • nausea1,095
  • dizziness1,075
  • headache1,075
  • diarrhoea1,056
  • drug ineffective1,039
  • arthralgia1,021
  • hypotension952
  • pruritus931
  • off label use905
  • pyrexia897
  • hypersensitivity847

Reports by year received

View as table
YearReports
2004500
2005507
2006366
2007256
2008263
2009261
2010346
2011334
2012459
2013426
2014504
2015445
2016572
2017521
2018473
2019502
2020675
2021990
20221,520
20231,163
20241,429
20251,387
2026824

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,039,436 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypotensionSignal9526.86.44,734
hypersensitivitySignal8476.56.13,990
fallSignal1,1845.14.83,943
dyspnoeaSignal1,6264.13.93,921
pyrexiaSignal8973.73.51,798
arthralgiaSignal1,0213.53.31,866
pruritusSignal9313.53.31,658
painSignal1,4183.33.12,338
dizzinessSignal1,0753.12.91,545
fatigueSignal1,3722.52.41,303
headacheSignal1,0752.52.3950
diarrhoeaSignal1,0562.32.2833
nausea1,0952.01.9548
off label use9051.51.4145
drug ineffective1,0391.11.116

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.